www.scientificamerican.com
2 months agoHealth
The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works
Semaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individuals
The approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events [ more ]